KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Times Interest Earned (2016 - 2022)

NovoCure's Times Interest Earned history spans 9 years, with the latest figure at -$9.48 for Q2 2022.

  • For Q2 2022, Times Interest Earned rose 27.5% year-over-year to -$9.48; the TTM value through Mar 2023 reached -$66.86, down 909.94%, while the annual FY2021 figure was -$5.73, 331.66% down from the prior year.
  • Times Interest Earned for Q2 2022 was -$9.48 at NovoCure, down from -$0.47 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $3.77 in Q3 2020 and bottomed at -$13.08 in Q2 2021.
  • The 5-year median for Times Interest Earned is -$1.79 (2018), against an average of -$2.27.
  • The largest annual shift saw Times Interest Earned skyrocketed 4121.37% in 2020 before it plummeted 1318.08% in 2022.
  • A 5-year view of Times Interest Earned shows it stood at -$4.01 in 2018, then soared by 102.19% to $0.09 in 2019, then surged by 4121.37% to $3.7 in 2020, then plummeted by 390.65% to -$10.76 in 2021, then grew by 11.85% to -$9.48 in 2022.
  • Per Business Quant, the three most recent readings for NVCR's Times Interest Earned are -$9.48 (Q2 2022), -$0.47 (Q1 2022), and -$10.76 (Q4 2021).